ClinicalTrials.govpublic full text
Intranasal Ketamine for Pain Control in Patients with Sickle Cell Disease and Vaso-occlusive Episode (VOE) in the PED
sickle cell disease, vaso-occlusive pain episode in sickle cell disease, vaso-occlusive crisis, ketamine, intranasal ketamine, analgesia, interventional, phase3
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 1009070
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.